Hexa Reports Market Research Reports and Insightful Company Profiles Global Obesity Treatment Market Size, Share, Strategies, Global Insights, Analysis and Forecasts, 2016 To 2024 The global obesity treatment market is expected to reach USD 15.6 billion by 2024, according to a new report by Grand View Research, Inc. Upward trend in sedentary lifestyles, physical inactivity, and unhealthy food habits are the vital factors responsible for the high prevalence of obesity. According to the Institute of Health Metrics and Evaluation, about 30.0% of the global population is either obese or overweight. Additionally, along with commercial availability of solutions for weight management, technological advancements introduced by the vertical players and supportive initiatives undertaken by the governments, create more awareness with regard to obesity and its impact on health. This is further driving the growth of the obesity treatment market. There are various approaches for weight management such as diet, exercise, drugs, minimally invasive devices & implants, and surgeries. Amongst the prevalent drugs, the combination drugs hold the largest market share whereas satiety drugs that provide a feeling of fullness appear as the fastest growing segment in the obesity treatment market. In surgeries, gastric bypass procedures form the largest growing segment whereas the minimally invasive endoscopic procedure segment that involves surgical placement of implants and devices, such as satiety devices and gastric empting devices, is the fastest growing space. Browse Detail Report With TOC@ http://www.hexareports.com/report/obesity-treatmentmarket/details Intense competition in the private sector has driven advancements and innovation toward the development of the latest techniques for obesity treatment that are offered in private hospitals and clinics. As a result, the demand for minimally invasive procedures is swiftly increasing. In addition, Hexa Reports Market Research Reports and Insightful Company Profiles increasing awareness of obesity & the associated diseases and the commercial availability of weight management solutions is propelling the obesity treatment market. Further key findings from the study suggest: The combination drugs segment for obesity captured the largest market share of around 53% of the global market in 2015. The largest share of the segment was mainly attributed to the rising prevalence of obesity and the synergistic effect of combination therapy in weight management. In the surgeries and devices segment, gastric bypass is the largest growing with a market share of over 32%, while the minimally invasive endoscopic procedures segment is anticipated to be the fastest growing category in obesity treatment for the forecast period North America accounts for the largest market share of around 52.0% in 2015. This region is expected to maintain its dominance throughout the forecast period due to the heavy R&D investments deployed to develop effective weight management solutions and the commercial availability of minimally invasive procedures. Asia Pacific is anticipated to witness the fastest growth during the forecast period. Growing awareness of adverse health effects related to excess weight and its impact amongst individuals, rising disposable income, improving healthcare infrastructure, and the emerging medical tourism industry are some of the factors expected to drive the growth of the Asia Pacific sector during the forecast period. Some key market participants include VIVUS, Inc., Arena Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, Allergan Plc, Medtronic, Ethicon (subsidiary of Johnson & Johnson), Cousin Biotech, EnteroMedics, Inc., and USGI Medical, Inc. The players are focusing on product innovation through extensive R&D activities and introducing new combination drugs & satiety products. In addition, the sector giants are developing minimally invasive procedures and initiating collaborations to expand their geographical territories to gain greater market presence. Request A Sample copy of This Report @ http://www.hexareports.com/sample/159457 Table Of Content Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data Analysis Chapter 2 Executive Summary Chapter 3 Market Snapshot Hexa Reports Market Research Reports and Insightful Company Profiles Chapter 4 Market Variables, Trends & Scope 4.1 Market Segmentation & Scope 4.1.1 Market Driver Analysis 4.1.1.1. Growing global prevalence of obesity 4.1.1.2. Changing lifestyles and food habits 4.1.1.3. Demand for minimally invasive procedures 4.1.1.4. Rising awareness about the different bariatric surgeries 4.1.2 Market Restraint Analysis 4.1.2.1.Complexities related to obesity treatment 4.1.2.2.High cost associated to surgeries 4.1.2.3. Limited insurance coverage 4.2 Obesity Treatment Market - SWOT Analysis 4.3 Industry Analysis - Porter's Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis 5.1.Obesity Treatment Market: Product Movement Analysis 5.1.1. Combination drugs 5.1.2. Appetite supressants 5.1.3. Malabsorption 5.1.4. Satiety Chapter 6 Market Categorization 2: Surgery & Devices Estimates & Trend Analysis 6.1. Obesity Treatment Market: Surgery & Devices Movement Analysis 6.1.1. Adjustable gastric banding 6.1.2. Roux-en-Y gastric bypass 6.1.3. Sleeve gastrectomy 6.1.4. Billiopancreatic diversion with duodenal switch 6.1.5. Endoscopic procedures 6.1.6. Others Browse Full Report @ http://www.hexareports.com/report/obesity-treatment-market/details About Us: Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Hexa Reports Market Research Reports and Insightful Company Profiles Contact Information: Ryan Shaw Felton Office Plaza, 6265 Highway 9, Felton, California, 95018, United States Phone Number 1-800-489-3075 Email Us: sales@hexareports.com Our Website: http://www.hexareports.com/ Visit Our Blogs: http://hexareports.blogspot.in
The global obesity treatment market is expected to reach USD 15.6 billion by 2024, according to a new report by Grand View Research, Inc. Upward trend in sedentary lifestyles, physical inactivity, and unhealthy food habits are the vital factors responsible for the high prevalence of obesity
© Copyright 2024 Paperzz
